GILEAD SCIENCES INC
GILDNASDAQ🏆 #84 by market capEarnings Oct 28Biotech
$135.77▲ $2.77 (+2.04%)
Market closed · at close1h—
24h▲ 2.0%
7d▲ 3.0%
14d▲ 2.3%
30d▲ 3.3%
1y▲ 13.1%
🏦Market Cap
$168.57B
Mid Cap
📈Revenue Growth (YoY)
+5.5%
Slowing
📊Gross Margin
79.6%
High
💵FCF Margin
41.8%
Strong
⚖️P/S Ratio
5.4x
Fair
Otter Score
50
Weak
Earnings
Q3 · 2026Reported 2026-08-04Earnings Per Share
Actual
-6.75
Expected
-7.25
beat
+6.90%
YoY −435.80%
Revenue
Actual
$7.80B
Expected
$7.40B
beat
+5.50%
YoY +10.20%
Consensus estimates
Recent quarters
Q3 2026
-6.75
beat
Q2 2026
2.03
beat
Q1 2026
1.86
beat
Q4 2025
2.47
beat